EVVV EV3 (MM)

ev3 Inc. (Nasdaq:EVVV) today announced that Shawn McCormick, senior vice president and chief financial officer, is scheduled to present at the 2010 Citi Investment Research Global Health Care Conference at 11:00 a.m. Eastern Time on Thursday, May 27, 2010, at the Hilton New York located at 1335 6th Avenue, (between 53rd & 54th), New York, NY.

To access the webcast, go to the investor relations section of the ev3 Web site at http://ir.ev3.net and click on the Webcast icon. The Webcast will be available for replay approximately one hour after the presentation is complete.

About ev3 Inc.

Since its founding in 2000, ev3 has been dedicated to developing innovative and breakthrough technologies for the endovascular treatment of peripheral vascular and neurovascular diseases. The company offers a comprehensive portfolio of treatment options, including the primary interventional technologies used today -- plaque excision systems, peripheral angioplasty balloons, stents, embolic protection devices, liquid embolics, embolization coils, flow diversion, thrombectomy catheters and occlusion balloons. More information about the company and its products can be found at http://www.ev3.net.    

ev3 and the ev3 logo are trademarks of ev3 Inc., registered in the U.S. and other countries.

CONTACT:  ev3 Inc.
          INVESTORS and MEDIA
          Julie Tracy, Sr. Vice President, Chief Communications Officer
          (949) 680-1375
          jtracy@ev3.net